Compagnie Lombard Odier S Cm A Aurinia Pharmaceuticals Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $5.66 Billion
- Q2 2024
A detailed history of Compagnie Lombard Odier S Cm A transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 65,000 shares of AUPH stock, worth $471,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
65,000
Previous 25,000
160.0%
Holding current value
$471,900
Previous $125,000
196.8%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUPH
# of Institutions
191Shares Held
56.2MCall Options Held
499KPut Options Held
637K-
Armistice Capital, LLC New York, NY11.1MShares$80.8 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$67.3 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$28.8 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$20.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$20.2 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.03B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...